Abstract | BACKGROUND: OBJECTIVE: METHOD: Twenty-five participants with DSM-IV trichotillomania participated in a 12-week, randomized, double-blind, placebo-controlled trial of flexible-dose olanzapine for trichotillomania. Recruitment occurred between August 2001 and December 2005, and follow-up was completed in February 2006. The primary outcome measure was the Clinical Global Impressions-Improvement (CGI-I) scale, and secondary measures of efficacy included the Yale-Brown Obsessive Compulsive Scale for Trichotillomania (TTM-YBOCS) and the Clinical Global Impressions-Severity of Illness (CGI-S) scale. RESULTS: Eleven of 13 participants (85%) in the olanzapine group and 2 of 12 (17%) in the placebo group were considered responders according to the CGI-I (P = .001). There was a significant change from baseline to end point in the TTM-YBOCS (P < .01) and the CGI-S (P < .001). The mean ± SD dose of olanzapine at end point was 10.8 ± 5.7 mg/d. Twenty-one of 25 patients (84%) reported at least 1 adverse event, but no adverse events resulted in early withdrawal from the study. CONCLUSION: TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00182507.
|
Authors | Michael Van Ameringen, Catherine Mancini, Beth Patterson, Mark Bennett, Jonathan Oakman |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 71
Issue 10
Pg. 1336-43
(Oct 2010)
ISSN: 1555-2101 [Electronic] United States |
PMID | 20441724
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © Copyright 2010 Physicians Postgraduate Press, Inc. |
Chemical References |
- Antipsychotic Agents
- Placebos
- Benzodiazepines
- Olanzapine
|
Topics |
- Adolescent
- Adult
- Antipsychotic Agents
(administration & dosage, adverse effects, therapeutic use)
- Benzodiazepines
(administration & dosage, adverse effects, therapeutic use)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Olanzapine
- Placebos
- Psychiatric Status Rating Scales
- Severity of Illness Index
- Trichotillomania
(drug therapy)
|